Grow with us!
At the heart of AOTI’s success are its employees! We care as much about what you can do as well as what you have done.
As an international, growing company, AOTI offers rewarding careers that allow you to help people live fuller, healthier lives. At AOTI you can be part of this, doing work that matters while living your best life personally and professionally.
We firmly believe that by fostering an environment built on INTEGRITY, PEOPLE FIRST, INNOVATION, PRODUCT LEADERSHIP and OPERATIONAL EXCELLENCE and HEALTH EQUITY—we can help ensure that our best years are yet to come.
We offer a robust and broad array of affordable benefits that allow you to select a total package that historically has drawn and retained the greatest talent.
Your needs are foremost when it comes to time off, paid holidays, medical, dental and vision insurance, 401(k) with a match, benefit allowance and much more!
Career Opportunities
Territory Manager – Westdeutschland - Verkauf der Wundversorgung AOTI ist der weltweit führende Anbieter von multimodaler topischer Sauerstofftherapie für Wunden. Unsere patentierte, nicht-invasive Topische Wund-Sauerstofftherapie (TWO2) ist das einzige Gerät, das in randomisierten kontrollierten Studien (RCT) und Real-World-Evidence-Studien (RWE) nachgewiesen hat, diabetische Fußgeschwüre…
AOTI is the global leader in multimodality topical wound oxygen therapy. Our patented non-invasive Topical Wound Oxygen (TWO2) therapy is the only device that has demonstrated in Randomized Controlled Trial (RCT) and Real-World Evidence (RWE) studies to heal Diabetic Foot Ulcers (DFUs), resulting in an unprecedented 88 percent reduction in hospitalizations and 71 percent reduction in amputations…
AOTI is the global leader in multimodality topical wound oxygen therapy. Our patented non-invasive Topical Wound Oxygen (TWO2) therapy is the only device that has demonstrated in Randomized Controlled Trial (RCT) and Real-World Evidence (RWE) studies to heal Diabetic Foot Ulcers (DFUs), resulting in an unprecedented 88 percent reduction in hospitalizations and 71 percent reduction in amputations…
AOTI is the global leader in multimodality topical wound oxygen therapy. Our patented non-invasive Topical Wound Oxygen (TWO2) therapy is the only device that has demonstrated in Randomized Controlled Trial (RCT) and Real-World Evidence (RWE) studies to heal Diabetic Foot Ulcers (DFUs), resulting in an unprecedented 88 percent reduction in hospitalizations and 71 percent reduction in amputations…
Advanced Oxygen Therapy, Inc. (AOTI) provides innovative solutions to help resolve chronic non-healing and acute complex wounds. We operate on the core values of Innovation, Scientific Leadership, Health Equity, People First, and Integrity. AOTI is recognized as a leader in wound care technology around the world. With a leading international management team, an extensive worldwide…
AOTI is the global leader in multimodality topical wound oxygen therapy. Our patented non-invasive Topical Wound Oxygen (TWO2) therapy is the only device that has demonstrated in Randomized Controlled Trial (RCT) and Real-World Evidence (RWE) studies to heal Diabetic Foot Ulcers (DFUs), resulting in an unprecedented 88 percent reduction in hospitalizations and 71 percent reduction in amputations…
AOTI is the global leader in multimodality topical wound oxygen therapy. Our patented non-invasive Topical Wound Oxygen (TWO2) therapy is the only device that has demonstrated in Randomized Controlled Trial (RCT) and Real-World Evidence (RWE) studies to heal Diabetic Foot Ulcers (DFUs), resulting in an unprecedented 88 percent reduction in hospitalizations and 71 percent reduction in amputations…
AOTI is the global leader in multimodality topical wound oxygen therapy. Our patented non-invasive Topical Wound Oxygen (TWO2) therapy is the only device that has demonstrated in Randomized Controlled Trial (RCT) and Real-World Evidence (RWE) studies to heal Diabetic Foot Ulcers (DFUs), resulting in an unprecedented 88 percent reduction in hospitalizations and 71 percent reduction in amputations…
Job Summary The Patient Services Representative, Collections Lead will be responsible for leading, supporting, and training for the timely and accurate collections of account receivables for all insurances and third-party billers along with partnering with the prior authorization and billing departments to maximize company revenue. General Accountabilities Help train new hires on process…
AOTI is the global leader in multimodality topical wound oxygen therapy. Our patented non-invasive Topical Wound Oxygen (TWO2) therapy is the only device that has demonstrated in Randomized Controlled Trial (RCT) and Real-World Evidence (RWE) studies to heal Diabetic Foot Ulcers (DFUs), resulting in an unprecedented 88 percent reduction in hospitalizations and 71 percent reduction in amputations…
AOTI is the global leader in multimodality topical wound oxygen therapy. Our patented non-invasive Topical Wound Oxygen (TWO2) therapy is the only device that has demonstrated in Randomized Controlled Trial (RCT) and Real-World Evidence (RWE) studies to heal Diabetic Foot Ulcers (DFUs), resulting in an unprecedented 88 percent reduction in hospitalizations and 71 percent reduction in amputations…
AOTI is the global leader in multimodality topical wound oxygen therapy. Our patented non-invasive Topical Wound Oxygen (TWO2) therapy is the only device that has demonstrated in Randomized Controlled Trial (RCT) and Real-World Evidence (RWE) studies to heal Diabetic Foot Ulcers (DFUs), resulting in an unprecedented 88 percent reduction in hospitalizations and 71 percent reduction in amputations…
AOTI is the global leader in multimodality topical wound oxygen therapy. Our patented non-invasive Topical Wound Oxygen (TWO2) therapy is the only device that has demonstrated in Randomized Controlled Trial (RCT) and Real-World Evidence (RWE) studies to heal Diabetic Foot Ulcers (DFUs), resulting in an unprecedented 88 percent reduction in hospitalizations and 71 percent reduction in amputations…
Advanced Oxygen Therapy, Inc. (AOTI) provides innovative solutions to help resolve chronic non-healing and acute complex wounds. We operate on the core values of Innovation, Scientific Leadership, Health Equity, People First, and Integrity. AOTI is recognized as a leader in wound care technology around the world. With a leading international management team, an extensive worldwide…
AOTI is the global leader in multimodality topical wound oxygen therapy. Our patented non-invasive Topical Wound Oxygen (TWO2) therapy is the only device that has demonstrated in Randomized Controlled Trial (RCT) and Real-World Evidence (RWE) studies to heal Diabetic Foot Ulcers (DFUs), resulting in an unprecedented 88 percent reduction in hospitalizations and 71 percent reduction in amputations…
AOTI is the global leader in multimodality topical wound oxygen therapy. Our patented non-invasive Topical Wound Oxygen (TWO2) therapy is the only device that has demonstrated in Randomized Controlled Trial (RCT) and Real-World Evidence (RWE) studies to heal Diabetic Foot Ulcers (DFUs), resulting in an unprecedented 88 percent reduction in hospitalizations and 71 percent reduction in amputations…
AOTI is the global leader in multimodality topical wound oxygen therapy. Our patented non-invasive Topical Wound Oxygen (TWO2) therapy is the only device that has demonstrated in Randomized Controlled Trial (RCT) and Real-World Evidence (RWE) studies to heal Diabetic Foot Ulcers (DFUs), resulting in an unprecedented 88 percent reduction in hospitalizations and 71 percent reduction in amputations…